C07C 311/01
Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
C07C311/01 (Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms) appears on 1,418 US grants and 1,323 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,418
- Published applications
- 1,323
- Assignees
- 608
- Inventors
- 4,641
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 7 | 0 |
| 1978 | 8 | 0 |
| 1979 | 3 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 9 | 0 |
| 1990 | 17 | 0 |
| 1991 | 18 | 0 |
| 1992 | 25 | 0 |
| 1993 | 18 | 0 |
| 1994 | 20 | 0 |
| 1995 | 30 | 0 |
| 1996 | 36 | 0 |
| 1997 | 50 | 0 |
| 1998 | 43 | 0 |
| 1999 | 39 | 0 |
| 2000 | 43 | 0 |
| 2001 | 65 | 9 |
| 2002 | 59 | 60 |
| 2003 | 71 | 81 |
| 2004 | 39 | 99 |
| 2005 | 41 | 64 |
| 2006 | 37 | 76 |
| 2007 | 47 | 69 |
| 2008 | 43 | 52 |
| 2009 | 48 | 71 |
| 2010 | 50 | 69 |
| 2011 | 47 | 56 |
| 2012 | 43 | 58 |
| 2013 | 38 | 45 |
| 2014 | 52 | 53 |
| 2015 | 44 | 48 |
| 2016 | 34 | 44 |
| 2017 | 46 | 54 |
| 2018 | 36 | 35 |
| 2019 | 33 | 44 |
| 2020 | 28 | 37 |
| 2021 | 28 | 29 |
| 2022 | 17 | 37 |
| 2023 | 16 | 38 |
| 2024 | 19 | 47 |
| 2025 | 25 | 23 |
| 2026 | 13 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Compound, corrosion inhibitor, and lubricant composition15 Sep 2026US 12,735,393 B2Idemitsu Kosan Co., Ltd.
- Herbicidal tetrazole compounds25 Aug 2026US 12,715,849 B2Syngenta Crop Protection AG
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Amino group eliminating agent, reaction product production method, reaction precursor, reaction precursor production method, and optically active reaction product production method24 Sep 2026US 2026/0285806 A1Mitsubishi Materials Electronic Chemicals Co., Ltd.
- Sulfonamides With Activity in Acute Kidney Injury and Fibrosis10 Sep 2026US 2026/0263415 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Compounds and method for upregulation of p53 through induction of mdm2 degradation3 Sep 2026US 2026/0257987 A1Georgia State University Research Foundation, Inc.
- Alkali metal ion conductor, alkali metal ion battery, and method for manufacturing alkali metal ion conductor27 Aug 2026US 2026/0253974 A1Toyota Jidosha Kabushiki Kaisha
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
Most cited
By later US patents
- 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2206US 5,604,260 AMerck Frosst Canada, Inc. · 1997
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018